This program is supported by an independent education grant from Lilly. This online education program has been designed for healthcare professionals globally excluding the UK.

Join internationally recognized Alzheimer’s disease experts Brad Dickerson, MD & Tammie Benzinger, MD for this free, accredited online teaching session exploring the latest evidence in identifying, mitigating, and managing ARIA in Alzheimer's Disease.

Accreditation:

• 1 AMA PRA Category 1 Credit™

Session Highlights

This session uses real-world clinical vignettes to examine the newest evidence guiding ARIA detection, management, and coordinated response across multidisciplinary teams.

• Examine the latest evidence base guiding patient-centered ARIA risk discussions. Through an APOE4+ case, faculty compare approaches to integrating emerging ARIA risk data, patient preferences, and eligibility considerations within contemporary shared decision-making.
• Review subtle early ARIA presentations with updated radiologic and clinical insights. Explore real-world MRI examples and early symptom patterns, with faculty discussing current interpretation nuances and how evolving evidence informs decision thresholds.
• Explore current strategies for ARIA risk mitigation across diverse clinical scenarios. Using a prior ARIA-H case, faculty discuss evidence-informed approaches to dose adjustment, MRI surveillance timing, and APOE-based risk considerations as reflected in the newest guidance.
• Discuss multidisciplinary ARIA escalation pathways shaped by emerging data. Walk through a suspected ARIA event from ED presentation to radiology and neurology coordination, highlighting workflow variations, communication practices, and system-level considerations reflected in recent evidence.

Who Should Attend?

This program is designed for healthcare professionals involved in Alzheimer’s disease diagnosis, imaging, treatment, and acute evaluation, including:

• Neurologists
• Radiologists and Neuroradiologists
• Emergency Medicine Physicians
• Psychiatrists and Geriatric Psychiatrists
• Primary Care Physicians (MD/DO)
• Nurse Practitioners and Physician Assistants
• Infusion Center Staff
• Nursing Staff
• Triage Specialists
• Frontline Clinical Support Teams

Faculty

Brad Dickerson, MD, is Professor of Neurology at Harvard Medical School and directs both the Frontotemporal Disorders Unit and the Neuroimaging Core of the MGH Alzheimer’s Disease Research Center at Massachusetts General Hospital. A leading behavioral neurologist, he specializes in Alzheimer’s disease, primary progressive aphasia, and related neurodegenerative conditions, with expertise in advanced neuroimaging and diagnostic biomarkers. He has published extensively, leads a multidisciplinary research team, mentors trainees, and serves in national advisory roles for the Alzheimer’s Association and the Association for Frontotemporal Degeneration.

Tammie L. S. Benzinger, MD, PhD, is the Hugh Monroe Wilson Professor of Radiology and Chief of MRI Service at the Mallinckrodt Institute of Radiology at Washington University School of Medicine. Her work focuses on PET and MRI biomarkers for Alzheimer’s disease and related neurodegenerative disorders, and she directs imaging programs for the Knight Alzheimer’s Disease Research Center, DIAN, and DIAN-TU. A recognized leader in neuroradiology, she has received multiple national awards and is known for advancing early detection of degenerative brain disease through innovative imaging science.

Program Schedule:

15 min - Brad Dickerson, MD. Design individualized treatment plans for early AD that balance patient/caregiver goals with ARIA risk-mitigation strategies.

10 min - Tammie L. S. Benzinger, MD, PhD. Accurately detect and classify early ARIA (ARIA-E and ARIA-H) on MRI or by symptom recognition.

10 min - Tammie L. S. Benzinger, MD, PhD. Integrate dose-modification tactics and MRI scheduling protocols into treatment plans for patients on anti-amyloid therapies.

15 min - Brad Dickerson, MD. Implement multidisciplinary ARIA response protocols, including urgent radiology communication, EMR alerts, and cross-specialty coordination.

10 min - Questions and Answers

Continuing Education Information

Commercial support: This activity received monetary support through an independent education grant from Lilly.

This continuing education activity will be provided by AffinityCE and MedAll. This activity will provide continuing education credit for physicians. A statement of participation is available to other attendees.

Disclosures

Tammie Benzinger, MD, PhD has disclosed financial interests or relationships within the past 24 months with the following ineligible companies: Research Support / Grants: NIH/NIA, Alzheimer’s Association, GHR Foundation, Anonymous Foundation, Dominantly Inherited Alzheimer Network (DIAN) Trials Unit (TU) Pharma Consortium, Hope Center for Neurological Disorders, Barnes-Jewish Hospital Foundation, NIH-AMP, American Society for Neuroradiology, Eli Lily/Avid Radiopharmaceuticals, LMI/Lantheus, Siemens, Hyperfine; Clinical Trials (Investigator): Eli Lilly, Roche, Biogen, J&J, Eisai; Consulting/Advisory Board: Biogen, Eisai, Lilly, Bristol Myers, J&J, Merck, Siemens; Travel: J&J, Eisai. Dr. Benzinger intends to discuss non-FDA uses of drug products and/or devices only in relation to products for which she has no financial relationships. She will disclose to the audience when this discussion takes place.

Brad Dickerson, MD, has disclosed financial interests or relationships within the past 24 months with the following ineligible companies: Consultant for Biogen, Lantheus, Lilly, Novo Nordisk; Data and Safety Monitoring Board for Merck. Dr. Dickerson does not intend to reference any unlabeled or unapproved uses of products during the presentation.

These disclosures are made in accordance with ACCME standards to ensure transparency and objectivity in continuing education.

AffinityCE staff, MedAll staff, as well as planners and reviewers, have no relevant financial relationships with ineligible companies to disclose.

Mitigation of Relevant Financial Relationships

AffinityCE adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible companies. Relevant financial relationships were mitigated by the peer review of content by non-conflicted reviewers prior to the commencement of the program.

Activity Accreditation for Health Professions

Physicians

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and MedAll. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.

AffinityCE designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and MedAll. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.

AffinityCE designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physician assistants should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Practitioners

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and MedAll. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.

AffinityCE designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Nurse practitioners should claim only the credit commensurate with the extent of their participation in the activity.

Nurses & Other Professionals

All other health care professionals completing this continuing education activity will be issued a statement of participation indicating the number of hours of continuing education credit. This may be used for professional education CE credit. Please consult your accrediting organization or licensing board for their acceptance of this CE activity.

System Requirements

Mobile device (e.g., large-format smart phone; laptop or tablet computer) or desktop computer with a video display of at least 1024 × 768 pixels at 24-bit color depth, capable of connecting to the Internet at broadband or faster speeds, with a current version Internet browser and popular document viewing software (e.g., Microsoft Office, PDF viewer, image viewer) installed. Support for streaming or downloadable audio-visual materials (e.g., streaming MP4, MP3 audio) in hardware and software may be required to view, review, or participate in portions of the program.

Unapproved and/or off-label use disclosure

AffinityCE/MedAll requires CE faculty to disclose to the participants:

• When products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not US Food and Drug Administration [FDA] approved); and
• Any limitations on the information presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion.

CME Inquiries

For all CME policy-related inquiries, please contact us at ce@affinityced.com.

Participation Costs

There is no cost to participate in this program.

EBAC® CME Information:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the European Board for Accreditation of Continuing Education for Health Professionals (EBAC)

MedAll is an EBAC accredited provider since 2025. The European Board for Accreditation of Continuing Education for Health Professionals (EBAC) accredits Continuing Education (CE) programmes for the international medical community.

This program is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC®) for 1 hour of effective education time.

In compliance with EBAC guidelines, all speakers/ chairpersons participating in this programme have disclosed or indicated potential conflicts of interest which might cause a bias in the presentations. The Organizing Committee/Course Director is responsible for ensuring that all potential conflicts of interest relevant to the event are declared to the audience prior to the CE activities.

EBAC® holds an agreement on mutual recognition of substantive equivalency with the US Accreditation Council for CME (ACCME) and the Royal College of Physicians and Surgeons of Canada, respectively.

Through an agreement between the European Board for Accreditation of Continuing Education for Health Professionals (EBAC®) and the American Medical Association, physicians may convert EBAC® External CME credits to AMA PRA Category 1 Credits. Information on the process to convert EBAC® credit to AMA credit can be found on the AMA website. Other healthcare professionals may obtain from the AMA a certificate of participation in an activity eligible for conversion of credit to AMA PRA Category 1 Credit.

The Accreditation Council for Continuing Medical Education (ACCME) and the Royal College of Physicians and Surgeons of Canada hold an agreement on substantial equivalency of accreditation systems with EBAC.

EBAC® is a member of the International Academy for CPD Accreditation (IACPDA) and a partner member of the International Association of Medical Regulatory Authorities (IAMRA).

How to Obtain Your EBAC® CME Credit:

To obtain your CME credit and acquire your certificate, please join the webinar and complete the evaluation at the end. You will receive a link to your certificate after completing the evaluation.

Disclaimer

This activity is intended for educational purposes only and does not establish a standard of care or replace clinical judgment. Any therapeutic or diagnostic strategies discussed must be evaluated in the context of each patient’s clinical circumstances, risks, and current evidence.

Learners should consult authoritative clinical guidelines and approved product information when considering treatment decisions.

All materials are used with permission. The views expressed are those of the faculty and do not necessarily reflect those of the accredited providers, MedAll, or any supporters.

Content is accurate as of the date of release.

This continuing education activity is active starting January 20th 2026, and will expire on January 20th 2026. Estimated time to complete this activity: 60 minutes.